Heron Therapeutics Inc. (HRTX)
Market Closed
17 Jul, 20:00
$
0. 47
-0.01
-2.0833%
$
65.45M Market Cap
- P/E Ratio
- Div Yield
1.68M Volume
-0.96 Eps
$ 0.48
Previous Close 
Want to track HRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Heron Therapeutics Inc. (HRTX) Statistics
Valuation metrics
Market Cap 65.45M
Enterprise value 189.86M
Trailing P/E (ttm) -2.66
Forward P/E 2.33
PEG ratio 0.01
Price/Sales (ttm) 0.49
Price/Book (mrq) 9.77
Enterprise Value/Revenue 1.26
Enterprise Value/EBITDA -7.87
Overview
Shares outstanding 188.31M
Float 133.67M
Shares short 41.15M
% Held by insiders 0.01%
% Held by institutions 0.84%
Average volume (10 days) 1.68M
Average volume (90 days) 2.64M
Price summary
52-Week low 0.38
52-Week high 2.05
Beta 1.42
50-Day moving average 0.42
200-Day moving average 1.06
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 13 Jan 2014
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.21%
Operating margin -0.07%
Operational effectiveness
Return on assets -0.13%
Return on equity -11.15%
Income Statement
Revenue (ttm) 154.9M
Revenue per share (ttm) 0.79
Quarterly revenue growth (yoy) -0.01%
Gross profit (ttm) 112.52M
EBITDA 3.06M
Net income to common (ttm) -20.2M
Diluted EPS (ttm) -0.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 46.63M
Total cash per share (mrq) 0.24
Total debt (mrq) 140.64M
Total Debt/Equity (mrq) 15.5
Current ratio (mrq) 2.53%
Book value per share (mrq) 0.05
Cash Flow
Cash flow statement -27.59M
Levered free cash flow (LFCF) -28.46M
